Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Program-level predictors of antipsychotic medication adherence among parolees.

Farabee D, Shen H, Sanchez S.

Int J Offender Ther Comp Criminol. 2004 Oct;48(5):561-71.

PMID:
15358931
2.

Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors.

Valenstein M, Blow FC, Copeland LA, McCarthy JF, Zeber JE, Gillon L, Bingham CR, Stavenger T.

Schizophr Bull. 2004;30(2):255-64.

PMID:
15279044
3.

The effects of race and criminal justice involvement on access to atypical antipsychotic medications among persons with schizophrenia.

Van Dorn RA, Swanson JW, Swartz MS, Elbogen EB.

Ment Health Serv Res. 2005 Jun;7(2):123-34.

PMID:
15974158
4.

Treatment adherence with antipsychotic medications in bipolar disorder.

Sajatovic M, Valenstein M, Blow FC, Ganoczy D, Ignacio RV.

Bipolar Disord. 2006 Jun;8(3):232-41.

PMID:
16696824
5.

Adherence to atypical antipsychotic treatment among newly treated patients: a population-based study in schizophrenia.

Cooper D, Moisan J, Grégoire JP.

J Clin Psychiatry. 2007 Jun;68(6):818-25.

PMID:
17592904
6.

A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia.

Ascher-Svanum H, Zhu B, Faries D, Lacro JP, Dolder CR.

J Clin Psychiatry. 2006 Jul;67(7):1114-23.

PMID:
16889456
7.

Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review.

Valenstein M, Ganoczy D, McCarthy JF, Myra Kim H, Lee TA, Blow FC.

J Clin Psychiatry. 2006 Oct;67(10):1542-50.

PMID:
17107245
8.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

PMID:
16707074
9.

A prospective evaluation of adherence to medication in first episode schizophrenia.

Kamali M, Kelly BD, Clarke M, Browne S, Gervin M, Kinsella A, Lane A, Larkin C, O'Callaghan E.

Eur Psychiatry. 2006 Jan;21(1):29-33.

PMID:
16460918
10.

Antipsychotic prescribing patterns in the Texas prison system.

Baillargeon J, Contreras SA.

J Am Acad Psychiatry Law. 2001;29(1):48-53.

PMID:
11302386
11.

Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence.

Lambert M, Conus P, Eide P, Mass R, Karow A, Moritz S, Golks D, Naber D.

Eur Psychiatry. 2004 Nov;19(7):415-22.

PMID:
15504648
12.

Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.

Day JC, Bentall RP, Roberts C, Randall F, Rogers A, Cattell D, Healy D, Rae P, Power C.

Arch Gen Psychiatry. 2005 Jul;62(7):717-24.

PMID:
15997012
13.
14.

A cross-sectional study of patients' perspectives on adherence to antipsychotic medication: depot versus oral.

Patel MX, de Zoysa N, Bernadt M, David AS.

J Clin Psychiatry. 2008 Oct;69(10):1548-56.

PMID:
19192437
15.

Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.

Barbui C, Kikkert M, Mazzi MA, Becker T, Bindman J, Schene A, Nosè M, Helm H, Thornicroft G, Tansella M.

Psychopathology. 2009;42(5):311-7. doi: 10.1159/000232973.

PMID:
19672133
16.

The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophrenia.

Haro JM, Salvador-Carulla L.

CNS Drugs. 2006;20(4):293-301. Review.

PMID:
16599647
17.

[Prescription practices of antipsychotic medication in early psychosis: a two-year follow-up survey of subjects admitted in two psychiatric hospitals of South-Western France].

Grolleau A, Cougnard A, Parrot M, Kalmi E, Desage A, Misdrahi D, Brun-Rousseau H, Verdoux H.

Encephale. 2007 May-Jun;33(3 Pt 1):326-31. French.

PMID:
17675930
18.

Clinical correlates of early medication adherence: West London first episode schizophrenia study.

Mutsatsa SH, Joyce EM, Hutton SB, Webb E, Gibbins H, Paul S, Barnes TR.

Acta Psychiatr Scand. 2003 Dec;108(6):439-46.

PMID:
14616225
19.

Guideline implementation and patient-tailoring strategies to improve medication adherence for schizophrenia.

Hudson TJ, Owen RR, Thrush CR, Armitage TL, Thapa P.

J Clin Psychiatry. 2008 Jan;69(1):74-80.

PMID:
18312040
20.

Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care.

Ascher-Svanum H, Faries DE, Zhu B, Ernst FR, Swartz MS, Swanson JW.

J Clin Psychiatry. 2006 Mar;67(3):453-60.

PMID:
16649833
Items per page

Supplemental Content

Support Center